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Immunoregulatory eicosanoids have been implicated inprotection frommycobacterial infection in cell and
animal models. Recently, a study of the zebraﬁsh embryo demonstrated that mutants of the lta4h gene,
which encodes the leukotriene A4 hydrolase (LTA4H) enzyme of the eicosanoid pathway, have hyper-
susceptibility to Mycobacterium marinum infection. It also reported that heterozygosity at the two single
nucleotide polymorphisms rs1978331 and rs2660898 located in introns of the LTA4H gene, a human
homologue of lta4h, is associated with protection from pulmonary tuberculosis. To replicate this associ-
ationwegenotyped six LTA4Hgenepolymorphisms in samples from3703pulmonary tuberculosis patients
and 5412 healthy controls collected in Russia. We found no evidence of the protective effect of heterozy-
gosity at the polymorphisms rs1978331 and rs2660898 (P¼ 0.29 and 0.49) and no association of the alleles
of any of the six polymorphisms (P¼ 0.13e0.81). These results suggest that commonpolymorphisms in the
LTA4H gene do not play any major role in susceptibility to clinical pulmonary tuberculosis.
 2010 Elsevier Ltd.Open access under CC BY license.1. Introduction
With approximately 9 million new cases and more than 1 million
deaths tuberculosis (TB) remains a global health problem.1 Although
one third of the world’s population is estimated to be infected with
Mycobacterium tuberculosis, less than 10% of the immuno-competent
individuals progress to clinical disease. Host susceptibility is, there-
fore, considered to be an important risk factor for the development of
active TB after M. tuberculosis infection, yet its underlying biological
mechanisms remain largely unknown. Several lines of evidence
indicate that genetic factors play an important role in susceptibility to
TB. For example, inbred animal strains demonstrate variable degree of
susceptibility or resistance to M. tuberculosis infection.2 In humans
monozygotic twins have higher TB concordance than dizygotic
twins.3,4 Furthermore, studies in human patients that have suscepti-
bility to the weakly virulent mycobacteria discovered rare mutations
in several immune genes, collectively known as Mendelian suscepti-
bility to mycobacterial disease (MSMD) syndrome.5x: þ44 1223 336 846.
entsev).
ense.Given the difﬁculties in studying the molecular biology of TB in
humans, much of our knowledge about mycobacterial infection
originates from animalmodels, especially mouse strains and guinea
pigs infected with M. tuberculosis2 and, more recently, zebraﬁsh
infected with its natural pathogenMycobacterium marinum, a close
relative ofM. tuberculosis.6 In a recent study Tobin et al. performed
a forward genetic screen in zebraﬁsh embryo and discovered a class
of mutants hypersusceptible to M. marinum infection, which dis-
played increased bacterial growth and reduced TNF signalling and
apparently was caused by mutations in the lta4h gene.7 This gene
encodes leukotriene A4 hydrolase (LTA4H) that is involved in the
synthesis of leukotriene B4 (LTB4), a proinﬂammatory eicosanoid
and a powerful chemoattractant. Mutations of the lta4h gene
reduced its expression and conferred hypersusceptibility to
M. marinum by redirecting leukotriene A4 (LTA4), the LTB4
precursor, to production of the anti-inﬂammatory lipoxin A4
(LXA4).7 These data are in line with previous ﬁndings that impli-
cated immunoregulatory eicosanoids in protection from mycobac-
terial infection in cell and animal models. Thus, LXA4 is known to
reduce resistance of mice to M. tuberculosis infection.8 Virulent
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which downregulated prostaglandin E2 that functions to activate
membrane repair and protect macrophages from M. tuberculosis-
induced necrosis.9,10
Tobin et al. then undertook a human genetic study, in which
they investigated polymorphisms in the LTA4H gene, a human
homologue of lta4h, for association with clinical TB and leprosy
phenotypes. They reported that heterozygosity at two intronic
single nucleotide polymorphisms (SNPs) in the LTA4H gene is
associated with protection from pulmonary and meningeal TB and
multibacillary leprosy without erythema nodosum leprosum.7 In
genetic association studies independent replication in large sample
collections is essential, given a large number of false associations
between sequence polymorphisms and various complex diseases
that have been reported previously.11,12 Therefore, here we studied
a collection of 9115 samples from pulmonary TB patients and
healthy controls in order to conﬁrm or refute association between
LTA4H polymorphisms and pulmonary TB.
2. Materials and methods
Pulmonary TB patients attending civilian TB dispensaries and TB
clinics along with healthy subjects attending the blood transfusion
service were recruited in two Russian cities, St. Petersburg and
Samara, as described previously.13 TB patients have been diagnosed
using information about TB contact, medical history and clinical
symptoms (cough, haemoptysis, chest pain, fever, weight loss),
presence of acid fast bacilli in sputum smear and had symptoms
characteristic of pulmonary TB on chest X rays. At the time of
diagnosis cavities were present in 70% of the patients. For all
patients in this study diagnosis has been conﬁrmed by culture ofM.
tuberculosis from sputum. We excluded from the study patients
with extra-pulmonary TB and all HIV-positive subjects. Controls
were healthy adult blood bank donors with no history of TB. In total
we studied 3703 culture-conﬁrmed pulmonary TB patients and
5412 controls, including 2004 patients and 2792 controls from St.
Petersburg and 1699 patients and 2620 controls from Samara.
We extracted genomic DNA from whole blood of the partici-
pating subjects using a standard chloroform/proteinase K protocol.
We checked DNA quality using 1% agarose gel electrophoresis,
determined DNA concentration using Picogreen reagent and then
normalised concentration for genotyping. We genotyped six LTA4H
SNPs using custom Taqman assays and 7900HT system from
Applied Biosystems (Table S1). We visually checked all genotype
clusters and assigned calls using SDS 2.3 software.
Allelic association analysis was done using Stata version 11.
Odds ratios and P-values were calculated by ManteleHaenszel testTable 1
LTA4H gene SNPs in Russian pulmonary TB patients and controls.
Genotype counts (frequencies, %)
SNP n 0.0 0.1
rs1978331 TB 3601 1267 (35.2) 1729 (48.0)
A ¼ 0 G ¼ 1 Controls 5238 1887 (36.0) 2546 (48.6)
rs17677715 TB 3599 2593 (72.0) 927 (25.8)
A ¼ 0 G ¼ 1 Controls 5247 3851 (73.4) 1292 (24.6)
rs2247570 TB 3595 1859 (51.7) 1437 (40.0)
A ¼ 0 G ¼ 1 Controls 5268 2751 (52.2) 2123 (40.3)
rs2660898 TB 3604 1607 (44.6) 1590 (44.1)
T ¼ 0 G ¼ 1 Controls 4894 2230 (45.6) 2160 (44.1)
rs2660845 TB 3595 258 (7.2) 1400 (38.9)
G ¼ 0 A ¼ 1 Controls 5264 371 (7.0) 2050 (38.9)
rs2540475 TB 3517 2385 (67.8) 1009 (28.7)
C ¼ 0 T ¼ 1 Controls 5198 3458 (66.5) 1597 (30.7)
SNP e single nucleotide polymorphism, MAF e minor allele frequency, OR e odds ratio,
* e OR and 95% CI for minor alleles are shown.
y e P-values for the allelic association were calculated by ManteleHaenszel test contrcontrolling for the city of the sample origin (St. Petersburg or
Samara). Statistical power calculations were done using EPITABLE
in Epi-info version 6 and Genetic Power Calculator.14
3. Results
We genotyped six LTA4H gene SNPs in 3703 HIV-negative adult
pulmonary TB patients and 5412 healthy controls from Russia.
Genotypesdidnotdeviate fromHardyeWeinbergequilibriumbeyond
that expected at random (Table 1). Initially we studied the allelic
effects of all six LTA4HSNPs, but foundnoevidenceof associationwith
TB for any of them (Table 1). We then compared frequencies of
heterozygotes versus homozygotes among TB cases and controls for
the rs1978331 and rs2660898 SNPs in order to conﬁrm or refute
protective effects of heterozygotes reported by Tobin et al. We found
no evidence of association: for rs1978331 odds ratio (OR)¼ 0.98, 95%
conﬁdence interval (95% CI) 0.90e1.06, Pone-tailed ¼ 0.29; for
rs2660898 OR ¼ 1.0, 95% CI ¼ 0.91e1.09, Pone-tailed ¼ 0.49 (genotype
counts are shown in Table 1). We did not test heterozygosity of the
other four SNPs for association with TB because they were not asso-
ciated with TB previously7 and because a biological model where
heterozygotes confer protection, while both homozygotes confer
susceptibility, is unlikely. A statistical test comparing numbers of
subjects heterozygous at both rs1978331 and rs2660898 and those
that are homozygous in at least one SNP also did not reveal any
signiﬁcant difference between TB patients and controls (proportions
of double heterozygoteswere 38.7% and 39.1%, respectively; P¼ 0.75).
4. Discussion
Tobin et al. genotyped six SNPs of the LTA4H gene in 658 pulmo-
nary and meningeal TB patients and 751 controls from Vietnam and
reported that protection from both pulmonary and meningeal TB is
associated with heterozygosity at two intronic SNPs, rs1978331 and
rs2660898 .7 Here we found no association between the same six
SNPs and pulmonary TB in the Russian population. Our study had
100% statistical power to detect at Pone-tailed ¼ 0.05 protective effects
of heterozygotes with OR¼ 0.64 and 0.71 reported for the rs1978331
and rs2660898 SNPs, respectively.7 Our studywas alsowell powered
to detect weaker allelic effects, e.g. > 90% power for OR  0.85 for
alleles of all six SNPs at Ptwotailed ¼ 0.05, assuming a multiplicative
genetic model. Therefore, it is very unlikely that we could miss
a genuine association in the Russian population. Of course, our study
does not replicate every aspect of the genetic association experiment
donebyTobinetal. Inparticular, herewestudiedaRussianpopulation
that has a European origin and is distinct from the Vietnamese and
Nepali populations, where associations with TB and leprosy,1.1 PHWE MAF (%) OR* (95% CI) P-valuey
605 (16.8) 0.71 40.8 1.05 (0.99e1.11) 0.13
805 (15.4) 0.26 39.7
79 (2.2) 0.72 15.1 1.06 (0.98e1.16) 0.15
104 (2.0) 0.72 14.3
299 (8.3) 0.37 28.3 1.03 (0.97e1.10) 0.34
394 (7.5) 0.57 27.6
407 (11.3) 0.65 33.4 1.05 (0.98e1.12) 0.18
504 (10.3) 0.57 32.4
1937 (53.9) 0.82 26.6 1.01 (0.94e1.08) 0.81
2843 (54.0) 0.96 26.5
123 (3.5) 0.20 17.8 0.98 (0.91e1.06) 0.66
143 (2.8) 0.01 18.1
95% CI e 95% conﬁdence interval.
olling for the origin of the sample.
Table S1
Probes and primers of the Taqman assays used for genotyping LTA4H SNPs
SNP Sequence
rs1978331 Forward Primer TGGAAAGTGAAGTCAATGCTGGTAT
Reverse Primer GCTCCCTATTTAGACCAGGTCATCA
Reporter (VIC) CATAGAACAGTGAACGGTGTG
Reporter (FAM) ATAGAACAGTGAACAGTGTG
rs17677715 Forward Primer AACAAAAAATTAAGAAGGAAGGGCACTTT
Reverse Primer ACTTGGAAGCCTACAAATATTACAGAAATGT
Reporter (VIC) AAGATATTTTATCAGTATTTTAC
Reporter (FAM) AAGATATTTTATCAATATTTTAC
rs2660898 Forward Primer TCATAAATTTGGAGGATCAAACTTCAGTGT
Reverse Primer GCTGAAGGAGACTTAATCGGACAAA
Reporter (VIC) CCCAAAACTGGAAAAG
Reporter (FAM) AACCCAAAACTTGAAAAG
rs2247570 Forward Primer GTGCAGCAATCTTGGGATAAGTG
Reverse Primer GTGTAGATTATACCAGCAGGGTTACTG
Reporter (VIC) AAATGCATTCTTGTATCTAAT
Reporter (FAM) TGCATTCTTGTGTCTAAT
rs2660845 Forward Primer ACTTCCTGTGGACTTCATAGTGTCT
Reverse Primer GGTGTATCGAGCCACTCAAGT
Reporter (VIC) CCACTGGCCCCACGGG
Reporter (FAM) CACTGGCCCCGCGGG
rs2540475 Forward Primer GCCAGCAGTTGTAAAGAACTTTTTCT
Reverse Primer CCTTCTCCCTACCCCAGCTT
Reporter (VIC) CCCTCCCTACTTCATC
Reporter (FAM) CCCTCCCTATTTCATC
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genetic polymorphisms on susceptibility to disease in various pop-
ulations cannot be excluded,we note that the choice of SNPs by Tobin
et al.wasdrivenby the associationof the LTA4HSNPswith the level of
LTB4 production that was originally reported in Icelanders, another
European population.15 This suggests that, if LTA4H SNPs are indeed
functional and inﬂuence susceptibility to TB, their effects would be
likely to be seen across different populations. We also note that
statistical evidenceof associationbetweenLTA4HSNPsandseveralTB
and leprosy phenotypes reported by Tobin et al. is rather weak
(P ¼ 0.021e4  105). Such associations are not uncommon when
multiple polymorphisms across many candidate genes are tested.
However, historically, genotype-phenotype associations that do not
reach strong statistical evidence (e.g. P < 107) have rarely been
replicated, suggesting that many of them arise due to chance,
a phenomenon that has been attributed to a low prior probability of
genetic association in complex diseases, multiple statistical testing
and relatively small datasets in the initial association reports.16e19
Inconsistent associations have been a problem in TB genetics, e.g.
associations in the SP110 and MAL/TIRAP genes have been repor-
ted,20,21 but were not conﬁrmed in the subsequent studies.13,22e24 A
lack of replication in this large sample collection indicates that
common LTA4H polymorphisms have no major effect on pulmonary
TB, at least in the Russian population. Further studies in statistically
powerful sample collections from Asia are required to deﬁnitively
conclude on the role of LTA4H in susceptibility to TB. Tobin et al. also
reported an even weaker statistical evidence suggesting that
heterozygosity at the LTA4H SNPs is associated with lower mortality
among patients with meningeal TB, as well as protection from
developing a multibacillary leprosy without erythema nodosum
leprosum(P¼ 0.025 and0.001, respectively). Herewedidnot address
these questions and they remain to be formally tested.
Studiesof animalmodels, includingzebraﬁsh,havebeenextremely
informative in uncovering underlying mechanisms of mycobacterial
infection.25,26 However, because of the natural differences between
thesemodels andhumans, relevanceof particularbiologicalpathways
to clinical TB is often difﬁcult to demonstrate. Human genetic studies
can address this crucial question at the aetiological level. Thus,
discovery of a genuine association between a genetic variant and
a disease indicates that a causative genetic factor exists in the vicinity
of the associated variant and, when mapped to a particular gene,
proves its aetiological contribution to human disease. Nevertheless,
statistically convincing and replicable evidence of association is
a prerequisite. Therefore, it still remains to be shownwhether genetic
variation in LTA4Hor other genes of the eicosanoidpathwayplays any
role in susceptibility to clinical TB.Funding: SN is a Royal Society University Research Fellow. This
study has been supported by the Royal Society Research grant, the
Wellcome Trust grant WT088838MA and the European Union
Framework Programme 7 grant 201483 to the TB-EUROGEN
consortium (FD, SN, RH and SH).
Competing interests: None declared.
Ethical approval: This work has been approved by Human
Biology Research Ethics Committees of the University of Cambridge
and of Queen Mary College, London and the local Ethics Commit-
tees in St. Petersburg and Samara, Russia. All participants provided
a written informed consent before being enrolled into the study.
Acknowledgements
We thank Irina Kontsevaya, SvetlanaMironova, Ivan Fedorin and
Nadezhda Malomanova for their help with sample collection.Appendix. Supplementary informationReferences
1. WHO. Global tuberculosis control: a short update to the 2009 report; 2009.
2. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004;22:599e623.
3. Kallmann FJ, Reisner D. Twin studies on the signiﬁcance of genetic factors in
tuberculosis. Am Rev Tuberc 1943;47:549e74.
4. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am
Rev Respir Dis 1978;117:621e4.
5. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the
human model. Annu Rev Immunol 2002;20:581e620.
6. Tobin DM, Ramakrishnan L. Comparative pathogenesis of Mycobacterium
marinum and Mycobacterium tuberculosis. Cell Microbiol 2008;10:1027e39.
7. Tobin DM, Vary Jr JC, Ray JP, Walsh GS, Dunstan SJ, Bang ND, et al. The lta4h
locus modulates susceptibility to mycobacterial infection in zebraﬁsh and
humans. Cell 2010;140:717e30.
8. Baﬁca A, Scanga CA, Serhan C, Machado F, White S, Sher A, et al. Host control of
Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin
production. J Clin Invest 2005;115:1601e6.
9. Chen M, Divangahi M, Gan H, Shin DS, Hong S, Lee DM, et al. Lipid mediators in
innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the
induction of macrophage death. J Exp Med 2008;205:2791e801.
10. Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, Lee DM, et al.
Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma
membrane repair. Nat Immunol 2009;10:899e906.
11. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, et al.
NCI-NHGRI working group on replication in association studies: replicating
genotype-phenotype associations. Nature 2007;447:655e60.
12. Behr M, Schurr E, Gros P. TB: screening for responses to a vile visitor. Cell
2010;140:615e8.
13. Szeszko JS, Healy B, Stevens H, Balabanova Y, Drobniewski F, Todd JA, et al.
Resequencing and association analysis of the SP110 gene in adult pulmonary
tuberculosis. Hum Genet 2007;121:155e60.
14. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and
association genetic mapping studies of complex traits. Bioinformatics
2003;19:149e50.
15. Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U,
Gudbjartsson DF, et al. A variant of the gene encoding leukotriene A4 hydrolase
confers ethnicity-speciﬁc risk of myocardial infarction.Nat Genet 2006;38:68e74.
16. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos Ioannidis DG. Replication
validity of genetic association studies. Nat Genet 2001;29:306e9.
17. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review
of genetic association studies. Genet Med 2002;4:45e61.
18. Colhoun HM, McKeigue PM, Davey-Smith G. Problems of reporting genetic
associations with complex outcomes. Lancet 2003;361:865e72.
19. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing
the probability that a positive report is false: an approach for molecular
epidemiology studies. J Natl Cancer Inst 2004;96:434e42.
J. Curtis et al. / Tuberculosis 91 (2011) 22e25 2520. Tosh K, Campbell SJ, Fielding K, Sillah J, Bah B, Gustafson P, et al. Variants in the
SP110 gene are associated with genetic susceptibility to tuberculosis in West
Africa. Proc Natl Acad Sci U S A 2006;103:10364e8.
21. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, et al.
A Mal functional variant is associated with protection against invasive
pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet
2007;39:523e8.
22. Thye T, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu Dabo E, et al. No
associations of human pulmonary tuberculosis with Sp110 variants. J Med
Genet 2006;43:e32.23. Babb C, Keet EH, van Helden PD, Hoal EG. SP110 polymorphisms are not
associated with pulmonary tuberculosis in a South African population. Hum
Genet 2007;121:521e2.
24. Nejentsev S, Thye T, Szeszko JS, Stevens H, Balabanova Y, Chinbuah AM, et al.
Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in
three populations. Nat Genet 2008;40:261e2.
25. Cosma CL, Humbert O, Ramakrishnan L. Superinfecting mycobacteria home to
established tuberculous granulomas. Nat Immunol 2004;5:828e35.
26. Lesley R, Ramakrishnan L. Insights into early mycobacterial pathogenesis from
the zebraﬁsh. Curr Opin Microbiol 2008;11:277e83.
